Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gerald Cox

Clinical Genetics (M.D.) Boston, MA Medical Doctor

NPI 1811955479 CMS profile 443805

300 Longwood Ave, Boston, MA 02115

Open in the dashboard

General payments

$474,596

45 records reported · program years 2019–2025

Research payments

$3,315

Paid to them · 4 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gerald Cox of Boston, MA is reported in the CMS Open Payments database as having received $474,596 across 45 general payments and $3,315 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Clinical Genetics (M.D.) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $110,960 11
2024 General $87,950 11
2023 General $54,000 3
2022 General $82,400 6
2021 General $106,000 10
2020 Research $3,171 2
2019 General $33,286 4
2019 Research $144 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gerald Cox
  • Clinical Genetics (M.D.) median
  • Middle half of Clinical Genetics (M.D.)
  • National median

In program year 2025, general payments to Gerald Cox were reported at $110,960. Among 315 Clinical Genetics (M.D.) profiles paid that year, the median was $255 and the middle half received between $85 and $3,583.

Show as a table
Year Gerald Cox Clinical Genetics (M.D.) median Middle half National median
2019 $33,286 $130 $24–$2,691 $163
2020 $0 $126 $30–$3,700 $114
2021 $106,000 $185 $30–$3,777 $132
2022 $82,400 $136 $44–$2,749 $149
2023 $54,000 $196 $55–$5,220 $160
2024 $87,950 $165 $46–$3,171 $164
2025 $110,960 $255 $85–$3,583 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Chiesi USA, Inc. $332,110 21 payments
  2. Ultragenyx Pharmaceutical Inc. $72,800 16 payments
  3. Vertex Pharmaceuticals Incorporated $33,286 4 payments
  4. Genzyme Corporation $30,225 3 payments
  5. Sentynl Therapeutics, Inc. $6,175 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $474,518 44 payments
  2. Travel and Lodging $78 1 payment
Research payments came from Research payments · program years 2019–2025
  1. Genzyme Corporation $3,315 4 payments

Records

49 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Genetics (M.D.) in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record